Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Leonid Timashev is an analyst at RBC Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/16/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/10/2024 | EWTX | Buy Now | Edgewise Therapeutics | $22.87 | 39.92% | $32 → $32 | Reiterates | Outperform → Outperform | Get Alert |
| 06/21/2024 | LEGN | Buy Now | Legend Biotech | $54.97 | 56.45% | $86 → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 06/18/2024 | BHVN | Buy Now | Biohaven | $38.45 | 53.45% | $59 → $59 | Reiterates | Outperform → Outperform | Get Alert |
| 06/07/2024 | NAMS | Buy Now | NewAmsterdam Pharma | $19.78 | 56.72% | $31 → $31 | Reiterates | Outperform → Outperform | Get Alert |
| 06/05/2024 | AXSM | Buy Now | Axsome Therapeutics | $82.80 | 57% | $127 → $130 | Maintains | Outperform | Get Alert |
| 05/14/2024 | LEGN | Buy Now | Legend Biotech | $54.97 | 56.45% | $85 → $86 | Maintains | Outperform | Get Alert |
| 04/22/2024 | EWTX | Buy Now | Edgewise Therapeutics | $22.87 | 39.92% | $28 → $32 | Maintains | Outperform | Get Alert |
| 04/09/2024 | BHVN | Buy Now | Biohaven | $38.45 | 58.65% | → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 03/26/2024 | AXSM | Buy Now | Axsome Therapeutics | $82.80 | 54.59% | $123 → $128 | Maintains | Outperform | Get Alert |
| 03/22/2024 | PYXS | Buy Now | Pyxis Oncology | $3.10 | 125.81% | → $7 | Reiterates | Outperform → Outperform | Get Alert |
| 03/20/2024 | DSGN | Buy Now | Design Therapeutics | $4.48 | -10.71% | → $4 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 03/12/2024 | LEGN | Buy Now | Legend Biotech | $54.97 | 54.63% | → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 03/12/2024 | EWTX | Buy Now | Edgewise Therapeutics | $22.87 | 22.43% | → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 03/08/2024 | LEGN | Buy Now | Legend Biotech | $54.97 | 54.63% | → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 03/07/2024 | LEGN | Buy Now | Legend Biotech | $54.97 | 54.63% | → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 03/01/2024 | BHVN | Buy Now | Biohaven | $38.45 | 58.65% | $62 → $61 | Maintains | Outperform | Get Alert |
| 02/29/2024 | NAMS | Buy Now | NewAmsterdam Pharma | $19.78 | 56.72% | $25 → $31 | Maintains | Outperform | Get Alert |
| 02/21/2024 | AXSM | Buy Now | Axsome Therapeutics | $82.80 | 48.55% | $126 → $123 | Maintains | Outperform | Get Alert |
| 02/16/2024 | BHVN | Buy Now | Biohaven | $38.45 | 61.25% | → $62 | Initiates | → Outperform | Get Alert |
| 01/25/2024 | AXSM | Buy Now | Axsome Therapeutics | $82.80 | 52.17% | → $126 | Initiates | → Outperform | Get Alert |
| 11/14/2023 | DSGN | Buy Now | Design Therapeutics | $4.48 | -10.71% | $7 → $4 | Maintains | Sector Perform | Get Alert |
| 10/30/2023 | NAMS | Buy Now | NewAmsterdam Pharma | $19.78 | 26.39% | → $25 | Initiates | → Outperform | Get Alert |
| 09/05/2023 | PYXS | Buy Now | Pyxis Oncology | $3.10 | 125.81% | → $7 | Initiates | → Outperform | Get Alert |
| 08/15/2023 | DSGN | Buy Now | Design Therapeutics | $4.48 | 56.25% | $23 → $7 | Downgrade | Outperform → Sector Perform | Get Alert |
| 06/28/2023 | EWTX | Buy Now | Edgewise Therapeutics | $22.87 | 22.43% | → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 06/16/2023 | LEGN | Buy Now | Legend Biotech | $54.97 | 50.99% | → $83 | Reiterates | Outperform → Outperform | Get Alert |
| 05/19/2023 | LEGN | Buy Now | Legend Biotech | $54.97 | 50.99% | $74 → $83 | Maintains | Outperform | Get Alert |
| 05/10/2023 | DSGN | Buy Now | Design Therapeutics | $4.48 | 413.39% | $24 → $23 | Maintains | Outperform | Get Alert |
| 03/24/2023 | LEGN | Buy Now | Legend Biotech | $54.97 | 32.8% | → $73 | Initiates | → Outperform | Get Alert |
| 03/15/2023 | DSGN | Buy Now | Design Therapeutics | $4.48 | 435.71% | → $24 | Reiterates | → Outperform | Get Alert |
| 12/08/2022 | DSGN | Buy Now | Design Therapeutics | $4.48 | 435.71% | $29 → $24 | Maintains | Outperform | Get Alert |
| 11/04/2022 | EWTX | Buy Now | Edgewise Therapeutics | $22.87 | 26.8% | $31 → $29 | Maintains | Outperform | Get Alert |
| 10/18/2022 | NBSE | Buy Now | NeuBase Therapeutics | — | — | $240 → $20 | Downgrade | Outperform → Sector Perform | Get Alert |
| 05/02/2022 | DSGN | Buy Now | Design Therapeutics | $4.48 | 569.64% | → $30 | Initiates | → Outperform | Get Alert |
| 04/13/2022 | EWTX | Buy Now | Edgewise Therapeutics | $22.87 | 35.55% | → $31 | Initiates | → Outperform | Get Alert |
